Fig. 3From: SGLT2-inhibitors effects on the coronary fibrous cap thickness and MACEs in diabetic patients with inducible myocardial ischemia and multi vessels non-obstructive coronary artery stenosisKaplan curves of the cumulative risk to have MACEs at 1 year of follow-up in SGLT2-I users vs. Non-SGLT2-I users. MACEs major adverse cardiac events, SGLT2-I sodium glucose transporter 2 inhibitorsBack to article page